Monday, October 26, 2026 · Daily editionET --:--:--

Not recruiting yet

5G Remote Robotic Surgery for Hepatic Echinococcosis in High-Altitude Region

NCT07551063 · West China Hospital · Updated 24 April 2026

What is being tested
5G-based Telerobotic Hepatectomy
For
Hepatic Echinococcosis
Kind of study
Tests a treatment or device on volunteers. Early phase 1.
Who can join
Ages 18 years to 80 years. About 10 people. The full rules are on the registry page.
Where
China
When
Starts or started 1 May 2026, ends 1 Oct 2026. Registered 24 April 2026.
Results
None posted yet.

In the researchers' words

Hepatic echinococcosis (HE) is a serious endemic parasitic disease in high-altitude regions like Xizang. Radical hepatectomy is the primary curative treatment, but expert resources are often concentrated in large medical centers. This prospective, single-arm study aims to evaluate the feasibility and safety of performing remote robotic hepatectomy using the Chinese Toumai™ robotic system over a 5G network. Ten patients in West China Hospital Tibet Hospital, Sichuan University (Lhasa, 3650m altitude) will undergo surgery performed by expert surgeons at West China Hospital (Chengdu). The primary focus is the surgical success rate and perioperative safety.
ClinicalTrials.gov, NCT07551063

Sites

  • West China Hospital, Sichuan UniversityChengdu, Sichuan / 四川, China